CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +7,500 | $25.60 | $192K | 12,539 |
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +4,405 | $36.60 | $161K | 16,944 |
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +8,200 | $27.00 | $221K | 25,144 |
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +2,733 | $27.00 | $74K | 27,877 |
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +16,658 | $27.60 | $460K | 44,535 |
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion | +13,225 | $46.00 | $608K | 57,760 |
| 2020-08-18 | Glenn Gregory M President, R&D | Sale | −6,288 | $143.94 | $905K | 51,472 |
| 2020-08-18 | Glenn Gregory M President, R&D | Sale | −31,957 | $145.00 | $4.6M | 19,515 |
| 2020-08-18 | Glenn Gregory M President, R&D | Sale | −17,151 | $146.00 | $2.5M | 2,364 |
| 2020-08-18 | Glenn Gregory M President, R&D | Sale | −525 | $146.58 | $77K | 1,839 |
| 2020-08-18 | Glenn Gregory M President, R&D | Gift | −1,528 | 311 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −3,200 | 0 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −4,405 | 0 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −8,200 | 550 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −2,733 | 6,017 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −16,658 | 8,341 | ||
| 2020-08-18 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −13,225 | 18,524 | ||
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion | +1,000 | $50.00 | $50K | 322,979 |
| 2020-08-18 | EVANS GARY C Director | Exercise or conversion | +1,500 | $36.60 | $55K | 324,479 |
Page 84 of 87 · 1,734 trades